J.‐L. Meynard

938 total citations
29 papers, 485 citations indexed

About

J.‐L. Meynard is a scholar working on Epidemiology, Infectious Diseases and Surgery. According to data from OpenAlex, J.‐L. Meynard has authored 29 papers receiving a total of 485 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Epidemiology, 15 papers in Infectious Diseases and 7 papers in Surgery. Recurrent topics in J.‐L. Meynard's work include Pneumocystis jirovecii pneumonia detection and treatment (6 papers), HIV/AIDS drug development and treatment (5 papers) and Tuberculosis Research and Epidemiology (4 papers). J.‐L. Meynard is often cited by papers focused on Pneumocystis jirovecii pneumonia detection and treatment (6 papers), HIV/AIDS drug development and treatment (5 papers) and Tuberculosis Research and Epidemiology (4 papers). J.‐L. Meynard collaborates with scholars based in France and United States. J.‐L. Meynard's co-authors include J Frottier, Marie‐Caroline Meyohas, Marguerite Guiguet, L. Fonquernie, Lefrère Jj, Martine Mariotti, Micheline Thauvin, Géraldine Guermonprez, Christine Katlama and Gilles Brücker and has published in prestigious journals such as Clinical Infectious Diseases, The Journal of Infectious Diseases and Journal of Hepatology.

In The Last Decade

J.‐L. Meynard

28 papers receiving 467 citations

Peers

Countries citing papers authored by J.‐L. Meynard

Since Specialization

Citations

This map shows the geographic impact of J.‐L. Meynard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.‐L. Meynard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.‐L. Meynard more than expected).

Fields of papers citing papers by J.‐L. Meynard

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.‐L. Meynard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.‐L. Meynard. The network helps show where J.‐L. Meynard may publish in the future.

Co-authorship network of co-authors of J.‐L. Meynard

This figure shows the co-authorship network connecting the top 25 collaborators of J.‐L. Meynard. A scholar is included among the top collaborators of J.‐L. Meynard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.‐L. Meynard. J.‐L. Meynard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Clinical and microbiological determinants of severe and fatal outcomes in patients infected with Enterobacteriaceae producing extended-spectrum β-lactamase 2017 ·European Journal of Clinical Microbiology & Infectious Diseases ·Laure Surgers, Anders Boyd, Pierre‐Yves Boëlle, V. Lalande, (unknown), Pierre‐Marie Girard, Guillaume Arlet, Carole Cambier, (unknown), Dominique Decré, J.‐L. Meynard	7
2	Vascularite de type purpura rhumatoïde révélant une séropositivité pour le VIH 2016 ·Médecine et Maladies Infectieuses ·(unknown), L. Fardet, P. Duriez, C Morin, Sébastien Rivière, J.‐L. Meynard, Laure Surgers	3
3	Diversity and combinations of infectious agents in 38 adults with an infection-triggered reactive haemophagocytic syndrome: a multicenter study 2015 ·Clinical Microbiology and Infection ·Nathalie Lerolle, Moussa Laanani, Sébastien Rivière, Lionel Galicier, Paul Coppo, J.‐L. Meynard, Jean‐Michel Molina, Élie Azoulay, Cédric Aumont, Christophe Marzac, L. Fardet, Olivier Lambotte	33
4	694 MDRD CREATININE CLEARANCE IS NOT ALTERED IN HIV-HBV CO-INFECTED PATIENTS WITH A NORMAL RENAL FUNCTION AND TREATED WITH TENOFOVIR (TDF) 2008 ·Journal of Hepatology ·Karine Lacombe, Alan Boyd, (unknown), Jean‐Michel Molina, Patrick Miailhes, J.‐L. Meynard, (unknown), A. Rachline, Laurent Cotte, Aldo Trylesinski, Pierre Marie Girard	2
5	Human Immunodeficiency Virus‐Associated Thrombotic Microangiopathies: Clinical Characteristics and Outcome According to ADAMTS13 Activity 2008 ·Scandinavian Journal of Immunology ·Sandra Malak, M. Wolf, Gaël A. Millot, Éric Mariotte, Agnès Veyradier, J.‐L. Meynard, J.M. Korach, Sandrine Malot, A Bussel, Élie Azoulay, Éric Boulanger, Lionel Galicier, (unknown), Valérie Eschwège, Sébastien Gallien, Christophe Adrie, Benoı̂t Schlemmer, Eric Rondeau, Paul Coppo	34
6	Urolithiasis in HIV-Positive Patients Treated with Atazanavir 2007 ·Clinical Infectious Diseases ·C. Couzigou, Michel Daudon, J.‐L. Meynard, (unknown), (unknown), L. Escaut, David Zucman, (unknown), (unknown), (unknown), T. May, D. Neau, Daniel Vittecoq	69
7	Dépistage et prévention des comorbidités chez les patients infectés par le VIH : le programme Orchestra Saint-Antoine 2007 ·Médecine et Maladies Infectieuses ·L. Fonquernie, (unknown), (unknown), Franck Boccara, (unknown), (unknown), Diane Bollens, (unknown), Jérôme Pacanowski, Karine Lacombe, J.‐L. Meynard, Marie‐Caroline Meyohas, Pierre‐Marie Girard	2
8	The long‐term benefits of genotypic resistance testing in patients with extensive prior antiretroviral therapy: a model‐based approach 2007 ·HIV Medicine ·Yazdan Yazdanpanah, Muriel Vray, J.‐L. Meynard, Elena Losina, (unknown), Laurence Morand‐Joubert, (unknown), Heather Hsu, Rochelle P. Walensky, Cécile Dalban, (unknown), (unknown), (unknown)	15
9	Imported concomitant coccidioidomycosis and histoplasmosis in an HIV-infected Colombian migrant in France 2005 ·Transactions of the Royal Society of Tropical Medicine and Hygiene ·Thierry Pistone, Karine Lacombe, J.L. Poirot, Pierre Marie Girard, J.‐L. Meynard	13
10	Impact of highly active antiretroviral therapy on the occurrence of bacteraemia in HIV‐infected patients and their epidemiologic characteristics 2003 ·HIV Medicine ·J.‐L. Meynard, Marguerite Guiguet, L. Fonquernie, Bénédicte Lefebvre, V. Lalande, Isabelle Honoré, (unknown), (unknown)	25
11	Facteurs prédictifs de réponse virologique à un traitement antirétroviral avec inhibiteur de protéase au cours de l'infection à VIH 2001 ·La Presse Médicale ·J.‐L. Meynard, Michel Guiguet, A. Rachline, Narjis Boukli, Diane Bollens, (unknown), J Frottier, Laurence Morand‐Joubert	1
12	Occurrence of Acute Hepatitis A in Patients Infected with Human Immunodeficiency Virus 2001 ·Clinical Infectious Diseases ·L. Fonquernie, J.‐L. Meynard, (unknown), Catherine Delamare, Marie‐Caroline Meyohas, J Frottier	35
13	Comparaison des cas de tuberculose pulmonaire isolée aux cas de tuberculose d'autre localisation dans un système de surveillance active (Gironde, 1995–1996) 1998 ·La Revue de Médecine Interne ·V. Daucourt, (unknown), (unknown), (unknown), (unknown), M. Dupon, J Texier-Maugein, J.‐L. Meynard, (unknown), François Dabis, Jean-François Tessier	4
14	[Paragonimiasis: a rare little known disease]. 1998 ·PubMed ·Jean–Baptiste Guiard–Schmid, Karine Lacombe, David Osman, J.‐L. Meynard, (unknown), Marie‐Caroline Meyohas, J Frottier	6
15	Rifampin-Resistant Mycobacterium kansasii Infection in a Patient with AIDS Who Was Receiving Rifabutin 1997 ·Clinical Infectious Diseases ·J.‐L. Meynard, V. Lalande, Marie‐Caroline Meyohas, J.C. Petit, J Frottier	3
16	Treatment of non-meningeal cryptococcosis in patients with AIDS 1996 ·Journal of Infection ·(unknown), J.‐L. Meynard, Diane Bollens, Patricia Roux, A M Deluol, J.L. Poirot, Willy Rozenbaum, C Mayaud, J Frottier	7
17	Risk Factors for Isolation of Streptococcus pneumoniae with Decreased Susceptibility to Penicillin G from Patients Infected with Human Immunodeficiency Virus 1996 ·Clinical Infectious Diseases ·J.‐L. Meynard, Frédéric Barbut, Livia Blum, Marguerite Guiguet, C. Chouaïd, M. C. Meyohas, Orit Picard, Jean‐Claude Petit, J Frottier	44
18	Detection of Human Herpesvirus 8 DNA Sequences before the Appearance of Kaposi's Sarcoma in Human Immunodeficiency Virus (HIV)-Positive Subjects with a Known Date of HIV Seroconversion 1996 ·The Journal of Infectious Diseases ·Lefrère Jj, Marie‐Caroline Meyohas, Martine Mariotti, J.‐L. Meynard, Micheline Thauvin, J Frottier	42
19	Herpes Simplex Esophagitis in Patients with AIDS: Report of 34 Cases 1996 ·Clinical Infectious Diseases ·T Généreau, Olivier Lortholary, Olivier Bouchaud, F. Lacassin, P Vinceneux, Pierre de Truchis, Arnaud Jaccard, J.‐L. Meynard, Renaud Verdon, D. Séréni, C Marche, (unknown), L Guillevin, (unknown)	37
20	[Clinical and comparative trial of dosulepin and amitriptyline]. 1978 ·PubMed ·(unknown), J.‐L. Meynard	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact